Early-onset colorectal cancer is increasing among younger adults, yet red-flag symptoms in this age group have no evidence-based guidelines for follow-up testing, and structured encounter data do not capture the detail needed to support early detection and inform follow-up, including symptom duration, context, and fam- ily history, an established colorectal-cancer risk factor. This study aimed to develop and evaluate an automated method for extracting six red-flag symptoms and family-history risk status from free-text clinical notes. We developed VERGE, an agentic workflow in which an initial label and evidence are proposed using retrieval-augmented generation, then passed through a bounded verification- refinement cycle that checks textual grounding and clinical validity, corrects and rechecks a claim until resolved or a limit is reached, and escalates unresolved claims for human review. VERGE was evaluated on 4,033 clinician-labeled note-finding pairs against a single-agent baseline, a rule-based clinical language-processing baseline, and an alternative underlying language model. Compared with the single-agent baseline, VERGE reduced false positive find- ings, improving precision from 0.764 to 0.849 and MCC from 0.681 to 0.730, a balanced gain across the precision-recall trade-off, and resolved most flagged errors autonomously, with human review required for only 1.5 percent of claims. These results indicate that a bounded, verification-based workflow can reduce unnecessary positive findings without sacrificing the ability to detect true ones. This approach offers a path toward more reliable and trustworthy clinical language-processing tools to support colorectal cancer risk assessment in younger patients.
Zero-shot LLMs substantially outperform rule-based and NER approaches for CRC symptom extraction; post-hoc negation correction should not be applied to LLM outputs without syntactic scope validation.
Y. Lee, I. Dinov, X. Hu et al.· medRxiv· 0 citations
This scalable method enables derivation of real-world endpoints from EHR-based data and may be used to characterize outcomes for patients treated outside of prospective clinical trials and may inform the creation of synthetic control cohorts to support regulatory approvals for new drugs in rare tumor or biomarker defin...
J. Lavery, Samantha Brown, Chelsea Nichols et al.· Cancer Epidemiology, Biomark...· 0 citations
LLM-extracted symptom data recover clinically coherent, reproducible SCs from unstructured discharge notes that carry independent prognostic value for mortality and readmission, supporting the clinical validity of automated, EHR-derived symptom profiling in CRC.
Y. Lee, I. Dinov, X. Hu et al.· medRxiv· 0 citations
Measured extraction performance varied substantially by matching definition, whereas exact-link decisions varied with the availability of matched terminology evidence, support separate evaluation of extraction, retrieval, evidence-grounded linking, and extension candidacy.
Background: Rare diseases affect an estimated 300 million people worldwide, yet the research needed to guide diagnosis and treatment is often fragmented across multiple unstructured literature sources. Natural history studies (NHS) are a key source of this evidence, but manually extracting structured information from N...
Background Late-stage cancer incidence is being considered as an earlier endpoint in cancer-screening trials, but its trial-level association with cancer-specific mortality may depend on evidence selection and endpoint harmonization. We evaluated the robustness of this association to source-verified additions. Methods...
S. Li, W. Zhang, X. Xing et al.· medRxiv· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduOct 15, 2026
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
Microsoft Research Blog· microsoft.comOct 15, 2026
Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.
MIT News · Artificial Intelligence· news.mit.eduSep 24, 2026